http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a00031f31e729cffebf4420729adfad6
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Lubiński |
| name | Jan Lubiński |
| given-name | Jan |
| organization-name | Department of Genetics and Pathology Pomeranian Medical University Szczecin Poland 24Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland; Read-Gene, Grzepnica, Alabastrowa 8, 72-003 Dobra, Poland Department of Genetics and Pathology; International Hereditary Cancer Centre; Pomeranian Medical University; Szczecin Poland International Hereditary Cancer Center Pomeranian Medical University Szczecin Poland Authors' Affiliations: 1Department of Health Sciences Research, Division of Epidemiology; 2Department of Medical Oncology; 3Department of Health Sciences Research, Division of Biomedical Statistics and Informatics; 4Department of Laboratory Medicine and Pathology, Division of Experimental Pathology; 5Department of Immunology; 6Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota; 7Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; 8Department of Epidemiology and Biostatistics; 9Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York; 10Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas; 11Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center; 12Women's Cancer Program, 13Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; 14Department of Medicine, Division of Hematology and Onco 31International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. Department of Genetics and Pathology International Hereditary Cancer Center Pomeranian Medical University Szczecin Poland Authors' Affiliations: 1Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA; 2Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA; 3Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA; 4Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA; 5Department of Oncology, University of Cambridge, Cambridge, UK; 6Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; 7Cancer Division, Queensland Institute of Medical Research, Herston, QLD, Australia; 8Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; 9Department of Epidemiology, University of Washington, Seattle, WA, USA; 10Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; 11Department of Epidemiology, Harvard School of Public Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland 47Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Departments of Department of Genetics and Pathology, Pomeranian Medical University , Szczecin, Poland Departmentof Genetics and Pathology International Hereditary Cancer Center, Pomeranian Medical University Szczecin Poland; Read‐Gene S.A., Grzepnica Dobra Szczecińska Poland Honglin Song, Ed Dicks, Jonathan P. Tyrer, Patricia Harrington, Jennifer Alsop, and Paul D.P. Pharoah, University of Cambridge; Mercedes Jimenez-Linan, Addenbrooke's Hospital, Cambridge; Jane Hayward, Lindsay Fraser, Susan Philpott, Christopher Anderson, Adam Rosenthal, Aleksandra Gentry-Maharaj, Usha Menon, and Ian J. Jacobs, University College London; David D. Bowtell, Imperial College London, London; Ian J. Jacobs, University of Manchester and Manchester Academic Health Science Centre, Manchester,... The authors’ affiliations are as follows: the Centre for Cancer Genetic Epidemiology, Departments of Public Health and Primary Care (L.D., S. Carvalho, J.A., K.A.P., Q.W., M.K.B., J.D., B.D., N. Mavaddat, K. Michailidou, A.C.A., P.D.P.P., D.F.E.) and Oncology (C.L., P.A.H., C. Baynes, D.M.C., L.F., V.R., M. Shah, P.D.P.P., A.M.D., D.F.E.), University of Cambridge, Cambridge, the Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine (A. Campbell, D.J.P.), and the... International Hereditary Cancer Center, Department of Genetics and Pathology Pomeranian Medical University Szczecin Poland Hereditary Cancer Center, Department of genetics and Pathology, Pomeranian Medical University, Ulica Polabska 4, 70-115 Szczecin, Poland Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, 71-252, Poland. Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, Poland; Read-Gene, Grzepnica, ul. Alabastrowa 8, 72-003 Dobra (Szczecińska), Poland Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University , 70-111 Szczecin , Poland 37International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. International Hereditary Cancer Center Department of Genetics and Pathology Pomeranian Medical University Szczecin Poland International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, 71-252 Szczecin, Poland Cezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Bartłomiej Masojć, Tadeusz Dębniak, Bohdan Górski, and Jan Lubiński, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Paweł Blecharz, Maria Sklodowska-Curie Memorial Institute, Kraków, Poland; and Steven A. Narod, Women's College Research Institute, Toronto, Ontario, Canada. Authors' Affiliations: Departments of 1Health Sciences Research, Division of Epidemiology, 2Medical Oncology, 3Health Sciences Research, Division of Biomedical Statistics and Informatics, 4Immunology, and 5Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, Minnesota; 6Department of Cancer Epidemiology, Division of Population Sciences, Moffitt Cancer Center, Tampa, Florida; 7Channing Division of Network Medicine, 8Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Harvard Medical School; 9Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 10Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut; 11Department of Clinical Science, University of Bergen; Departments of 12Gynecology and Obstetrics, and 13Pathology, Haukeland University Hospital, Bergen, Norway; Departments for 14Health Evidence, 15Urology, and 16Gynaecology, Radboud University Medical Centre, Nijmegen; 17 Department of Genetics and Pathology; International Hereditary Cancer Center, Pomeranian Medical University; Połabska 4 Szczecin 70-115 Poland Department of Genetics and Pathology, Pomeranian Medical University, Szczecin 71-252, Poland. Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland. Department of Genetics and Pathology, International Hereditary Cancer Center Pomeranian Medical University Szczecin Poland Authors' Affiliations: 1Queensland Institute for Medical Research, Brisbane, Australia; 2Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care; 3Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom; 4IARC, Lyon, France; 5University of Pennsylvania School of Medicine; 6Abramson Cancer Center; 7Fox Chase Cancer Center, Philadelphia, Pennsylvania; 8Medical University of Vienna, Waehringer Guertel, Vienna, Austria; 9Hereditary Cancer Risk Program at the Baylor-Sammons Cancer Center; 10University of Texas, Southwestern Medical Center, Dallas, Texas; 11Beth Israel Deaconess Medical Center; 12Dana Farber Cancer Institute, Boston, Massachusetts; 13City of Hope, Duarte; 14UCLA Schools of Medicine and Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, California; 15Creighton University, Omaha, Nebraska; 16Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Bohdan Górski, Pawel Domagała, Cezary Cybulski, Oleg Oszurek, and Jan Lubiński, Pomeranian Medical University, Szczecin; Marek Szwiec, Regional Oncology Center, Opole; Karol Gugała, District Specialist Hospital, Olsztyn; Malgorzata Stawicka, Regional Oncology Center, Poznań; Zbigniew Morawiec, Regional Oncology Center, Łódź; Tomasz Mierzwa, Regional Oncology Hospital; Hanna Janiszewska, Nicolaus Copernicus University, Bydgoszcz; Ewa Kilar, District... Authors' Affiliations: 1International Agency for Research on Cancer (IARC), Lyon, France; 2Gillings School of Global Public Health; 3School of Medicine; 4Otolaryngology/Head and Neck Surgery; and 5Lineberger Comprehensive Cancer Site, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 6University of Pittsburgh, Pittsburgh, Pennsylvania; 7Instituto de Investigación Epidemiológica, San José, Costa Rica; 8National Cancer Institute, IRCSS, Aviano, Italy; 9Brown University, Providence, Rhode Island; 10Boston University School of Public Health, Boston, Massachusetts; 11Department of Otorhinolaryngology and Head and Neck Surgery, Maastricht University Medical Site, Maastricht; and 12Department of Gastroenterology, Radboud University Nijmegen Medical Site, Nijmegen, the Netherlands; 13Pomeranian Medical University, Department of Genetics and Pathomorphology, International Hereditary Cancer Site, Szczecin, Poland; 14Penn State College of Medicine, Hershey, Pennsylvania; 15Un Pomeranian Medical University Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland Department of Genetics and Pathomorphology, Pomeranian Medical University, International Hereditary Cancer Center, 70-204 Szczecin, Poland Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland; These authors contributed equally to this work |
Incoming Links
Total number of triples: 326.